Evaluation method and screening method for sphingosine-1-phosphate 1 (S1P1) receptor agonists
Abstract:
It has been found that a main effect (immunosuppressive activity) of an S1P1 receptor agonist correlates with the selectivity for cells expressing a combination of an S1P1 receptor with Gαi2 or Gαi3, and that an adverse effect (cardiotoxicity) of an S1P1 receptor agonist correlates with the selectivity for cells expressing a combination of an S1P1 receptor with Gαi1.
Public/Granted literature
Information query
Patent Agency Ranking
0/0